Isradipine is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Actavis Pharma, Inc.. The primary component is Isradipine.
| Product ID | 16252-539_56d6cf92-6eac-482c-80fa-ada11302d71a |
| NDC | 16252-539 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Isradipine |
| Generic Name | Isradipine |
| Dosage Form | Capsule |
| Route of Administration | ORAL |
| Marketing Start Date | 2004-01-05 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA077317 |
| Labeler Name | Actavis Pharma, Inc. |
| Substance Name | ISRADIPINE |
| Active Ingredient Strength | 3 mg/1 |
| Pharm Classes | Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
| Marketing Start Date | 2004-01-05 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA077317 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2004-01-05 |
| Ingredient | Strength |
|---|---|
| ISRADIPINE | 2.5 mg/1 |
| SPL SET ID: | bf3425e0-428d-4bdb-ac9a-3b9d483df83a |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 16252-539 | Isradipine | Isradipine |
| 16252-540 | Isradipine | Isradipine |
| 42806-263 | Isradipine | Isradipine |
| 42806-264 | Isradipine | Isradipine |
| 50268-454 | Isradipine | Isradipine |
| 50268-455 | Isradipine | Isradipine |
| 60429-385 | Isradipine | Isradipine |
| 60429-386 | Isradipine | Isradipine |
| 64850-910 | Isradipine | Isradipine |
| 64850-911 | Isradipine | Isradipine |
| 68151-1333 | Isradipine | Isradipine |
| 68462-807 | Isradipine | Isradipine |
| 68462-808 | Isradipine | Isradipine |